Shenzhen HighTide Biopharmaceutical Ltd.
4 clinical trials · Sponsor
◉ Watch Shenzhen HighTide Biopharmaceutical Ltd.
| Record | Firm | Date |
|---|---|---|
| Effects of Berberine Ursodeoxycholate (HTD1801) Versus Dapagliflozin in Patients With Type 2 Diabetes Inadequately Controlled With Metformin (NCT06415773) | Shenzhen HighTide Biopharmaceutical Ltd. | 2024-06-04 |
| Efficacy and Safety of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2 Diabetes Inadequately Controlled With Metformin (NCT06353347) | Shenzhen HighTide Biopharmaceutical Ltd. | 2023-11-13 |
| Efficacy and Safety of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2 Diabetes (NCT06350890) | Shenzhen HighTide Biopharmaceutical Ltd. | 2023-11-05 |
| A Phase 2 Study of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2 Diabetes Inadequately Controlled With Diet and Exercise (NCT06411275) | Shenzhen HighTide Biopharmaceutical Ltd. | 2022-03-31 |
Track Shenzhen HighTide Biopharmaceutical Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.